Tebentafusp in advanced uveal melanoma: proof of principle for the efficacy of T-cell receptor therapeutics and bispecifics in solid tumors

Liu, A. W., Wei, A. Z., Maniar, A. B., & Carvajal, R. D. (2022). Tebentafusp in advanced uveal melanoma: proof of principle for the efficacy of T-cell receptor therapeutics and bispecifics in solid tumors. Expert Opinion on Biological Therapy, 22(8), 997–1004. https://doi.org/10.1080/14712598.2022.2031970
Authors:
Alex W Liu
Alexander Z Wei
Ashray B Maniar
Richard D Carvajal
Affiliated Authors:
Alexander Z Wei
Ashray B Maniar
Richard D Carvajal
Columbia Affiliation:
Subjects:
Immunoconjugates (MeSH)
Melanoma (MeSH)
Uveal Neoplasms (MeSH)
Author Keywords:
uveal melanoma
bispecific therapeutics
immunotherapy
tebentafusp
elink
Publication Type:
Article
Unique ID:
10.1080/14712598.2022.2031970
PMID:
35060440
DOI:
10.1080/14712598.2022.2031970
Journal:
Expert Opinion on Biological Therapy
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: